Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Kuhn

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Plos One|December 21, 2017
Accurate and fast feature selection workflow for high-dimensional omics dataYasset Perez-Riverol, Max Kuhn, Juan Antonio Vizcaíno, et al.
Journal of Pain Research|March 19, 2015
Electronic medical record data to identify variables associated with a fibromyalgia diagnosis: importance of health care resource utilizationElizabeth T Masters, Jack Mardekian, Birol Emir, et al.
Journal of Pain Research|June 20, 2015
Identification of a potential fibromyalgia diagnosis using random forest modeling applied to electronic medical recordsBirol Emir, Elizabeth T Masters, Jack Mardekian, et al.
The AAPS Journal|May 24, 2017
Ultra-Sensitive Measurement of IL-17A and IL-17F in Psoriasis Patient Serum and SkinCatherine Soderstrom, Gabriel Berstein, Weidong Zhang, et al.
Journal of Medicinal Chemistry|May 27, 2016
Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic StabilityMartin Pettersson, Xinjun Hou, Max Kuhn, et al.
Journal of Lipid Research|May 26, 2012
Silencing of enzymes involved in ceramide biosynthesis causes distinct global alterations of lipid homeostasis and gene expressionWanida Ruangsiriluk, Shaun E Grosskurth, Daniel Ziemek, et al.
Journal of Medicinal Chemistry|November 14, 2013
Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studiesTravis T Wager, Bethany L Kormos, Joseph T Brady, et al.
Bioorganic & Medicinal Chemistry|December 7, 2020
The advantages of describing covalent inhibitor in vitro potencies by IC<sub>50</sub> at a fixed time point. IC<sub>50</sub> determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimizationAtli Thorarensen, Paul Balbo, Mary E Banker, et al.
Plos One|July 2, 2010
Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant miceBarbara L Bernardo, Timothy S Wachtmann, Patricia G Cosgrove, et al.
BMC Genomics|June 3, 2011
Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetesJianxin Yang, Margit L MacDougall, Michael T McDowell, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Plos One|December 21, 2017
Accurate and fast feature selection workflow for high-dimensional omics dataYasset Perez-Riverol, Max Kuhn, Juan Antonio Vizcaíno, et al.
Journal of Pain Research|March 19, 2015
Electronic medical record data to identify variables associated with a fibromyalgia diagnosis: importance of health care resource utilizationElizabeth T Masters, Jack Mardekian, Birol Emir, et al.
Journal of Pain Research|June 20, 2015
Identification of a potential fibromyalgia diagnosis using random forest modeling applied to electronic medical recordsBirol Emir, Elizabeth T Masters, Jack Mardekian, et al.
The AAPS Journal|May 24, 2017
Ultra-Sensitive Measurement of IL-17A and IL-17F in Psoriasis Patient Serum and SkinCatherine Soderstrom, Gabriel Berstein, Weidong Zhang, et al.
Journal of Medicinal Chemistry|May 27, 2016
Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic StabilityMartin Pettersson, Xinjun Hou, Max Kuhn, et al.
Journal of Lipid Research|May 26, 2012
Silencing of enzymes involved in ceramide biosynthesis causes distinct global alterations of lipid homeostasis and gene expressionWanida Ruangsiriluk, Shaun E Grosskurth, Daniel Ziemek, et al.
Journal of Medicinal Chemistry|November 14, 2013
Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studiesTravis T Wager, Bethany L Kormos, Joseph T Brady, et al.
Bioorganic & Medicinal Chemistry|December 7, 2020
The advantages of describing covalent inhibitor in vitro potencies by IC<sub>50</sub> at a fixed time point. IC<sub>50</sub> determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimizationAtli Thorarensen, Paul Balbo, Mary E Banker, et al.
Plos One|July 2, 2010
Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant miceBarbara L Bernardo, Timothy S Wachtmann, Patricia G Cosgrove, et al.
BMC Genomics|June 3, 2011
Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetesJianxin Yang, Margit L MacDougall, Michael T McDowell, et al.
Pageof 3